Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005659700
Fri, 13.11.2026       Eckert & Ziegler SE

Company Name: Eckert & Ziegler SE ISIN: DE0005659700   Reason for the research: Update Recommendation: BUY Target price: EUR 21.50 Target price on sight of: 12 months Last rating change: Analyst: Simon Keller Q3 review: a stronger dose of earningsEckert & Ziegler's Q3 delivered a clear return to growth in adj. EBIT. Group [ … ]
Thu, 12.11.2026       Eckert & Ziegler SE

3rd quarter of 2026: Sales of €79.6 million (previous year: €75.3 million) EBIT before special items of €19.3 million (previous year: €15.4 million) Net income of €13.1 million (previous year: €8.5 million) First 9 months of 2026: Sales of €229.0 million (previous year: €224.1 million) EBIT before special items of €52.6 million (previous year: [ … ]
Wed, 28.10.2026       Eckert & Ziegler SE

Braunschweig, Germany, 28 October 2026. Eckert & Ziegler Therapeutics GmbH, wholly owned subsidiary of Eckert & Ziegler SE (ISIN DE0005659700, TecDAX), has received the manufacturing authorization for Actinium-225 (Ac-225). The certification by the competent German authority confirms that production meets the stringent requirements of Good  [ … ]
Thu, 13.08.2026       Eckert & Ziegler SE

2nd Quarter 2026: Sales: €76.4 million (PY: €80.6million) EBIT before special items: €17.4 million (PY: €19.2 million) Net income: €12.1 million (PY: €11.8 million) 1st Half Year 2026: Sales: €149.3 million (PY: €148.8 million) EBIT before special items: €33.3 million (PY: €35.4 million) Net income: €22.4 million (PY: €21.4 million) Forecast  [ … ]
Wed, 22.07.2026       Eckert & Ziegler SE

Berlin, July 22, 2026. Eckert & Ziegler SE announces that the Federal Financial Supervisory Authority (BaFin) has initiated a special review of the 2024 consolidated financial statements. BaFin is examining the extent to which Eckert & Ziegler SE’s controlling relationships precluded the off-balance-sheet write-off of Pentixapharm AG’s asse [ … ]
Thu, 28.05.2026       Eckert & Ziegler SE

Berlin, Germany and Oslo, Norway, 28 May 2026. Eckert & Ziegler SE (ISIN DE0005659700), a world-leading specialist in isotope-related components, equipment and services for nuclear medicine and radiation therapy, today signed a collaboration and supply agreement with Thor Medical, a leading emerging supplier of alpha-emitters for next-generatio [ … ]
Mon, 20.04.2026       Eckert & Ziegler SE

Company Name: Eckert & Ziegler SE ISIN: DE0005659700   Reason for the research: Update Recommendation: BUY Target price: EUR 23 Target price on sight of: 12 months Last rating change: Analyst: Simon Keller Q1 preview: Medical to continue growth trajectory EUZ Q1 26 results are due on May 12. We expect sales of € 72.5m (+ [ … ]
Fri, 10.04.2026       Eckert & Ziegler SE

Berlin, 10 April 2026. Eckert & Ziegler BEBIG GmbH, subsidiary of Eckert & Ziegler SE with focus on brachytherapy solutions for the treatment of eye tumors and prostate cancer, obtained the MDR certificate for its Ruthenium-106 (Ru-106) Eye Applicators from competent authorities. Eckert & Ziegler is the only global provider of these eye [ … ]
Mon, 16.02.2026       Eckert & Ziegler SE

Berlin, Germany and Řež, Czech Republic, 16 February 2026. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) and the Nuclear Physics Institute of the Czech Academy of Sciences (Ústav jaderné fyziky, “UJF”) have successfully transitioned their joint Actinium-225 initiative into larger scale manufacturing using the facilities in Řež and Braunschwei [ … ]
Thu, 05.02.2026       Eckert & Ziegler SE

Company Name: Eckert & Ziegler SE ISIN: DE0005659700   Reason for the research: Update Recommendation: BUY Target price: EUR 23 Target price on sight of: 12 months Last rating change: Analyst: Simon Keller Picks and shovels play intact, chg.Novo Nordisk’s c.17% share price drop underscores how quickly sentiment can turn [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 19.11.2026, Calendar Week 47, 323rd day of the year, 42 days remaining until EoY.